Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neurotox Res. 2013 Feb;23(2):131-44. doi: 10.1007/s12640-012-9348-1. Epub 2012 Aug 16.

Neuroinflammation, neurodegeneration, and depression.

Author information

  • 1Department of Pharmacology, College of Medicine, Howard University, 520 W Street NW, Washington, DC 20059, USA.

Abstract

Neurodegeneration and depression are two common co-morbid conditions, particularly within the aging population. Research has linked neuroinflammation as a major contributing factor to both of these diseases. The key to neuroinflammation effects on neurodegeneration and depression appears to lie within the dysregulation of the control and release of pro- and anti-inflammatory cytokines. This can come from an internal or external insult to the system, or from changes in the individual due to aging that culminate in immune dysregulation. The need to reduce neuroinflammation has led to extensive research into neuroprotectants. We discuss the efficacy found with nicotine, alcohol, resveratrol, curcumin, and ketamine. Our main focus will be on what research tells us about the connections between neuroinflammation, neurodegeneration, and depression, and the hope that neuroprotectants research gives people suffering from neurodegeneration and depression stemming from neuroinflammation. We will conclude by making suggestions for future research in this area.

PMID:
22895696
[PubMed - indexed for MEDLINE]
PMCID:
PMC3751583
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk